Status:
COMPLETED
Balance and Anti-Epileptic Drugs
Lead Sponsor:
Erik J. Kobylarz
Collaborating Sponsors:
American Epilepsy Society
Conditions:
Epilepsy
Eligibility:
All Genders
16-55 years
Phase:
NA
Brief Summary
Patients with epilepsy exercise less than the general population. A barrier to exercise may be the effect of antiepileptic drugs on balance and reaction time. This proposal endeavors to study the effe...
Detailed Description
Patients with epilepsy (PWE) exercise less compared to the general population. One barrier to participation in exercise is the subtle effect of anti epileptic drugs (AEDs) on balance and reaction time...
Eligibility Criteria
Inclusion
- Focal or generalized epilepsy
- On a stable dose of AEDs defined by no medication changes within the last month.
- On levetiracetam or lamotrigine monotherapy
Exclusion
- Inability to stand independently for 30 seconds
- Peripheral neuropathy
- History of stroke or previous brain surgery
- Seizure within last 24 hours
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2018
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT03338478
Start Date
December 1 2017
End Date
May 30 2018
Last Update
August 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756